Abstract
The immune system is a dynamic whole system network that, as a result of the interaction between genes, lifestyle and environment, is constantly remodeling itself throughout our lifespan. The immune response is driven by the complex interactions of up- and downregulating cytokines and chemokines. These families of proteins fine-tune effective responses to infection or tissue damage, through multiple layers of activation and control, regulated by soluble receptors, receptor antagonists, and diverse serum mediators, in order to maintain homeostatic immune balance.
With age, the immune system shows a persistent low-grade inflammation, controlled by the balance between pro-inflammatory and anti-inflammatory cytokines. A loosening of this cytokine balance has been called “inflamm-aging” or sterile inflammation and underpins most age-related disease from atherosclerosis, to diabetes, to Alzheimer’s disease, and aging itself. “Inflamm-aging” may derive in part, from age-related increases in senescence-associated secretory phenotype cells, which secrete pro-inflammatory mediators, together with an age-related decline in homeostatic immune function, increased fragility of epithelial barriers, and changes in the gut microbiome. Cytokine expression is known to be influenced by the local cellular environment, which accumulates age-related damage from reactive oxygen species, DNA and lipid damage, or incorrectly folded proteins.
Increasing knowledge about the molecular pathways underpinning the pro-inflammatory cytokine network should allow the development of therapeutic tools to reduce senescence-associated secretory phenotype cells or the use of deacetylating and demethylation agents to modify gene expression. At the human level, emerging understanding of the importance of external environments and the epigenome suggests that behavioral changes in lifestyle through diet, exercise, or social networks can and do influence the immune system.
Susan E. McNerlan and I. Maeve Rea contributed equally to this work.
References
Abe K, Hashimoto Y, Yatsushiro S, Yamamura S, Bando M, Hiroshima Y, Kido J, Tanaka M, Shinohara Y, Ooie T, Baba Y, Kataoka M (2013) Simultaneous immunoassay analysis of plasma IL-6 and TNF-α on a microchip. PLoS One 8(1):e53620
Agrawal A, Su H, Chen J, Osann C, Agrawal S, Gupta S (2012) Increased IL-21 secretion by aged CD4+ T cells is associated with prolonged STAT-4 activation and CMV seropositivity. Aging 4:648–659
Ansari WM, Humphries SE, Naveed AK, Khan OJ, Khan DA (2016) Influence of cytokine gene polymorphisms on pro-inflammatory/anti-inflammatory cytokine imbalance in premature coronary artery disease. Post Grad Med J 0:1–6
Armstrong ME, Alexander HD, Ritchie JL, McMillan SA, Rea IM (2001) Age-related alterations in basal expression and in vitro, tumour necrosis factor alpha mediated, upregulation of CD11b. Gerontology 47:180–185
Aspinall R (2006) T cell development, ageing and interleukin-7. Mech Ageing Dev 127:572–578
Baggiolini M, Clarke-Lewis I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307:97–101
Barnabe C, Martin BJ, Ghali WA (2011) Systematic review and meta-analysis: anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res 63:522–529
Battle A, Khan Z, Wang SH, Mitrano A, Ford MJ, Pritchard JK, Gilad Y (2015) Genomic variation. Impact of regulatory variation from RNA to protein. Science 347(6222):664–647
Beekman M, Blanché H, Perola M, Hervonen A, Bezrukov V, Sikora E, Flachsbart F, Christiansen L, De Craen AJ, Kirkwood TB, Rea IM, Poulain M, Robine JM, Valensin S, Stazi MA, Passarino G, Deiana L, Gonos ES, Paternoster L, Sørensen TI, Tan Q, Helmer Q, Van Den Akker EB, Deelen J, Martella F, Cordell HJ, Ayers KL, Vaupel JW, Törnwall O, Johnson TE, Schreiber S, Lathrop M, Skytthe A, Westendorp RG, Christensen K, Gampe J, Nebel A, Houwing-Duistermaat JJ, Slagboom PE, Franceschi C (2013) GEHA consortium. Genome-wide linkage analysis for human longevity: Genetics of Healthy Aging Study. Aging Cell 12(2):184–193
van den Biggelaar AHJ, Huizing TWJ, de Craen AJM, Gussekloo J, Heijmans BT, Frolich M, Westendorp RGJ (2004) Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol 39(9):1407–1414
Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C (2001) A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31:2357–2361
Brooks-Wilson AR (2013) Genetics of healthy aging and longevity. Hum Genet 132(12):1323–1338
Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK (1999) Impaired production of pro-inflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol 118:235–241
Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK (2000) Ageing, TNF-α and atherosclerosis. Clin Exp Immunol 121:255–260
Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK (2003a) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80 year old people. Clin Exp Immunol 132:24–31
Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JV, Pedersen BK, Jeune B (2003b) Elevated levels of tumour necrosis factor alpha and mortality in centenarians. Am J Med 115:278–283
Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F (1997) Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 27:756–762
Burks TN, Cohn RD (2011) Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle 1:19
Camargo A, Delgado-Lista J, Garcia-Rios A, Cruz-Teno C, Yubero-Serrano EM, Perez-Martinez P, Gutierrez-Mariscal FM, Lora-Aguilar P, Rodriguez-Cantalejo F, Fuentes-Jimenez F, Tinahones FJ, Malagon MM, Perez-Jimenez F, Lopez-Miranda J (2012) Expression of pro-in- flammatory, pro-atherogenic genes is reduced by the Mediterranean diet in elderly people. Br J Nutr 108(3):500–508
Carvalho A, Carvalho A, Rea IM, Parimon T, Cusack BJ (2014) Physical activity and cognitive function in individuals over 60 years of age: a systematic review. Clin Interv Aging 9:661–682
Cavallone L, Bonafe M, Olivieri F, Cardelli M, Marchegiani F, Giovagnetti S, Di Stasio G, Giampieri C, Mugianesi E, Stecconi R, Sciacca F, Grimaldi LM, De Benedictis G, Lio D, Caruso C, Franceschi C (2003) The role of IL-1 gene cluster in longevity: a study in Italian population. Mech Ageing Dev 124:533–538
Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, Vedin I, Wretlind B, Grimble RF, Palmblad J (2007) Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J Intern Med 262:215–223
Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Christensen K (2004) Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech Ageing Dev 125:391–395
Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8(1):18–30
Collins JS, Perry RT, Watson B Jr, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Campbell RD, Go RC (2000) Association of a haplotype for tumour necrosis factor in siblings with late-onset Alzheimer disease. The NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 96:823–830
Commins JW, Steinke L, Borish K (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108–1111
Compte N, Zouaoui Boudjeltia K, Vanhaeverbeek M, De Bruecker S, Tassignon J, Trelcat A, Pepersack T, Goriely S (2013) Frailty in old age is associated with decreased interleukin 12/23 production in response to toll-like receptor ligation. PLoS One 8:e65325
Coppé JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez P-Y, Campisi J (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6(12):2853–2868
Dai L, Liu D, LiGuo H, Wang Y, Bai Y (2012) Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis. J Neurol 259(3):414–419
Damsgaard CT, Lauritzen L, Calder PC, Kjær TM, Frøkiær H (2009) Whole-blood culture is a valid low-cost method to measure monocytic cytokines: a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J Immunol Methods 340:95–101
Deelen J, Beekman M, Uh HW, Broer L, Ayers KL, Tan Q, Kamatani Y, Bennet AM, Tamm R, Trompet S, Guðbjartsson DF, Flachsbart F, Rose G, Viktorin A, Fischer K, Nygaard M, Cordell HJ, Crocco P, Van Den Akker EB, Böhringer S, Helmer Q, Nelson CP, Saunders GI, Alver M, Andersen-Ranberg K, Breen ME, van der Breggen R, Caliebe A, Capri M, Cevenini E, Collerton JC, Dato S, Davies K, Ford I, Gampe J, Garagnani P, de Geus EJ, Harrow J, Van Heemst D, Heijmans BT, Heinsen FA, Hottenga JJ, Hofman A, Jeune B, Jonsson PV, Lathrop M, Lechner D, Martin-Ruiz C, Mcnerlan SE, Mihailov E, Montesanto A, Mooijaart SP, Murphy A, Nohr EA, Paternoster L, Postmus I, Rivadeneira F, Ross OA, Salvioli S, Sattar N, Schreiber S, Stefánsson H, Stott DJ, Tiemeier H, Uitterlinden AG, Westendorp RG, Willemsen G, Samani NJ, Galan P, Sørensen TI, Boomsma DI, Jukema JW, Rea IM, Passarino G, De Craen AJ, Christensen K, Nebel A, Stefánsson K, Metspalu A, Magnusson P, Blanché H, Christiansen L, Kirkwood TB, Van Duijn CM, Franceschi C, Houwing-Duistermaat JJ, Slagboom PE (2014) Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Hum Mol Genet 23(16):4420–4432
Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C, Hurme M, Mocchegiani E, Rea M, Lio D, Candore G, Caruso C (2009) Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 8:36–42
Di Iorio A, Ferrucci L, Sparvieri E, Cherubini A, Volpato S, Corsi A, Bonafè M, Franceschi C, Abate G, Paganelli R (2003) Serum IL-1beta levels in health and disease: a population based study. ‘The InCHIANTI Study’. Cytokine 22:198–205
Didion SP, Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM (2009) Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54(3):619–624
Dinarello CA (2006) Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83(2):447S–455S
Dinarello CA (2010) Anti-inflammatory agents: present and future. Cell 140(6):935–950
Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11(8):633–652. https://doi.org/10.1038/nrd3800
Donnelly RP, Dickensheets H, Finbloom DS (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interf Cytokine Res 19:563–573
Donnelly RP, Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H (2004) The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76:314–321
Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS (2010) TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation 7:62
Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF, Farrar GJ, Kiang A-S, Humphries MM, Lavelle EC, O’Neill LAJ, Hollyfield JG, Humphries P (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 18:791–798
Dupaul-Chicoine J, Yeretssian G, Doirin K, Bergstrom KS, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, Vallance BA, Saleh M (2010) Control of intestinal homeostasis, colitis and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32:367–378
Elosua R, Bartali B, Ordovas JM, Corsi AM, Lauretani F, Ferrucci L, InCHIANTI Investigators (2005) Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 60(6):760–767
Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41:176–181
Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Fallace R, Havlik RJ (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47:755–756
Ferruci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL (2005) The origins of age-related proinflammatory state. Blood 105(6):2294–2299
Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL- 6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376
Forsey RJ, Thompson JM, Ernerudh J, Hurst TL, Strindhall J, Johansson B, Nilsson BO, Wikby A (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev 124:487–493
Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4–S9
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Franceschi C, Bezrukov V, Blanché H, Bolund L, Christensen K, de Benedictis G, Deiana L, Gonos E, Hervonen A, Yang H, Jeune B, Kirkwood TB, Kristensen P, Leon A, Pelicci PG, Peltonen L, Poulain M, Rea IM, Remacle J, Robine JM, Schreiber S, Sikora E, Slagboom PE, Spazzafumo L, Stazi MA, Toussaint O, Vaupel JW (2007a) Genetics of healthy aging in Europe: the EU-integrated project GEHA (GEnetics of Healthy Aging). Ann N Y Acad Sci 1100:21–45
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panouraia MP, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007b) Inflammaging and antiinflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105. https://doi.org/10.1016/j.mad.2006.11.016
Franceschi C (2007c) Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 65(12):S173–S176. https://doi.org/10.1111/j.1753-4887.2007.tb00358.x
Frayling TM, Rafiq S, Murray A, Hurst AJ, Weedon MN, Henley W, Bandinelli S, Corsi AM, Ferrucci L, Guralnik JM, Wallace RB, Melzer D (2007) An interleukin-18 polymorphism is associated with reduced serum concentrations and better functioning in older people. J Gerontol A Biol Sci Med Sci 62:73–78
Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB (2009) Mediterranean diet, and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119:1093–1100
Gangemi S, Basileb G, Merendinoa RA, Minciulloa PL, Novickc D, Rubinstein M, Dinarello CA, Balbob CL, Franceschi C, Basilif S, D’Urbanog E, Davı G, Nicita-Maurob V, Mario Romanoi M (2003) Increased circulating interleukin-18 levels in centenarians with no sign of vascular disease: another paradox of longevity. Exp Gerontol 38:669–672
Govindaraju D, Atzmon G, Barzilai N (2015) Genetics, lifestyle and longevity: lessons from centenarians. Appl Transl Genom 4:23–32
Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93–97
Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J (1994) Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 15:771–772
Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512
Hedrich CM, Bream JH (2010) Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 47:185–206
Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T (2013) Slower immune system aging in women versus men in the Japanese population. Immun Ageing 10:19
Hofmann SR, Rösen-Wolff A, Tsokos GC, Hedrich CM (2012) Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol 142:116–127
Itoh S, Itoh F (2012) Implication of tgf-β as a survival factor during tumour development. J Biochem 151:559–562
Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Aselfa B, Khaled AR, Durum SK (2005) Cell biology of interleukin 7, a key lymphotrophin. Cytokine Growth Factor Rev 16:513–533
Jordan WJ, Eskdale J, Boniotto M, Lennon GP, Peat J, Campbell JDM, Gallagher G (2005) Human IL-19 regulates immunity through auto-induction of IL-19 production of IL-10. Eur J Imunol 35:1576–1582
Jylha M, Paavilainen, Lehtimäki T, Goebeler S, Karhunen PJ, Hervonen A, Hurme M (2007) Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci 62(9):1016–1021
Kinzenbaw DA, Chu Y, Peña Silva RA, Didion SP, Faraci FM (2013) Interleukin-10 protects against aging-induced endothelial dysfunction. Phys Rep 1(6):e00149
Knoops KTB, de Groot LM, Kromhout D, Perrin A-E, Moreiras-Varela O, Menotti A, van Staveren WA (2004) Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292(12):1433–1439
Krieglstein K, Miyazono K, Ten Dijke P, Unsicker K (2012) TGF-beta in aging and disease. Cell Tissue Res 347:5–9
Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S (2012) TGF-beta – an excellent servant but a bad master. J Transl Med 10:183. https://doi.org/10.1186/1479-5876-10-183
Kuningas M, May L, Tamm R, van Bodegom D, van den Biggelaar AH, Meij JJ, Frölich M, Ziem JB, Suchiman HE, Metspalu A, Slagboom PE, Westendorp RG (2009) Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population. PLoS One 4(11):e7795
Lakoski SG, Liu Y, Brosnihan KB, Herrington DM (2008) Interleukin-10 Concentration and Coronary Heart Disease (CHD) event risk in the Estrogen Replacement and Atherosclerosis (ERA) study. Atherosclerosis 197(1):443–447
Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF (2000) Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1–receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res 15(3):402–414
Leonard WJ, Spolski R (2005) Interleukin 21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5(9):688–698
Liao YC, Liang W-G, Chen F-W, Hsu J-H, Yang J-J, Chang M-S (2002) IL-19 induces production of IL-6 and TNF-α and results in cell apoptosis through TNF-α. J Immunol 169:4288–4297
Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Franceschi C, Caruso C (2002) Gender specific association between-1082 IL-10 promoter polymorphism and longevity. Genes Immun 3(1):30
Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C (2003) Inflammation, genetics and longevity: further studies on the prospective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 40:296–299
Liu L, Chan C (2014) The role of inflammasome in Alzheimer’s disease. Ageing Res Rev 0:6–15
de Lorgeril M, Salen P (2006) The mediterranean-style diet for the prevention of cardiovascular diseases. Public Health Nutr 9(1):118–123
Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI (2000) Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer’s disease. Hum Genet 106(5):565–569
Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A (2001) Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89(10):930–934
Mallat Z, Heymes C, Corbaz A, Logeart D, Alouani S, Cohen-Solal A, Seidler T, Hasenfuss G, Chvatchko Y, Shah AM, Tedgui A (2004) Evidence of altered interleukin (IL)-18 pathway in human heart failure. FASET J 18(14):1752–1754
Matteini AM, Li J, Lange EM, Tanaka T, Lange LA, Tracy RP, Wang Y, Biggs ML, Arking DE, Fallin MD, Chakravarti A, Psaty BM, Bandinelli S, Ferrucci L, Reiner AP, Walston JD (2014) Novel gene variants predict serum levels of cytokines IL-18 and Il-1ra in older adults. Cytokine 65(1):10–16
Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rüde E, Germann T (1993) The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 23:2202–2208
McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP (2001) Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer’s disease and vascular dementia: a case-control study. Lancet 357:436–439
McNerlan SE, Rea IM, Alexander HD (2002) A whole blood method for measurement of intracellular TNFα, IFNγ and IL-2 expression in stimulated CD3+ lymphocytes: differences between young and elderly subjects. Exp Gerontol 37:227–237
Mekli K, Marshall A, Nazroon J, Vanhoutte B, Pendleton N (2015) Genetic variant of Interleukin-18 gene is associated with the Frailty Index in the English Longitudinal Study of Ageing. Age Ageing 44(6):938–942
Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M, Nourhashemi F (2013) Pro-inflammatory cytokines, ageing aging, and age-related diseases. JAMDA 14(12):877–882
Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S, Basile G (2016) Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp 64:111–126
Mooijaart SP, Sattar N, Trompet S, Lucke J, Stott DJ, Ford I, Jukema JW, Westendorp RGJ, De Craen AJM, PROSPER Study Group (2013) Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J Intern Med 274:77–85
Moraes MO, Santos AR, Schonkeren JJ, Vanderborght PR, Ottenhoff TH, Moraes ME, Moraes JR, Sampaio EP, Sarno EN, Huizinga TW (2003) Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics 54:896–899
Mrak RE, Griffin WS (2000) Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 59(6):471–476
Mun M-J, Kim J-H, Choi J-Y, Jang W-C (2016) Genetic polymorphisms of interleukin genes and the risk of Alzheimer’s disease: an update meta-analysis. Meta Gene 8:1–10
Murabito JM, Yuan R, Lunetta KL (2012) The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J Gerontol A Biol Sci Med Sci 67(5):470–479
Naumova et al (2004) Immunological markers contributing to successful aging in Bulgarians. Exp Gerontol 39:637–644
Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H (1998) Relation between plasma tumour necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 18(8):1199
O’Mahoney L, Holland J, Jackson J, Feighery C, Hennessy TP, Mealy K (1998) Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin Exp Immunol 113(2):213–219
Okayama N, Suehiro Y, Hamanaka Y, Nakamura J, Hinoda Y (2007) Association of interleukin-19 gene polymorphisms with age. J Gerontol A Biol Sci Med Sci 62A(5):507–511
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71–109
Passtoors WM, Boer JM, Goeman JJ, Erik B, van Den A, Deelen J, Bas J, Zwaan SA, Van Der Breggen RM, Vossen RHA, Houwing-Duistermaat JJ, Van Ommen GJB, Westendorp RGJ, Van Heemst D, …, Slagboom PE (2012) Transcriptional prefiling of human familial longevity indicates a role for ASF1A and IL-7R. PLoS One 7(1):e27759
Passtoors WM, van den Akker EB, Deelen J, Maier AB, Van Der Breggen R, Jansen R, Trompet S, van Heemst D, Derhovanessian E, Pawelec G, van Ommen G-JB, Slagboom PE, Beekman M (2015) IL7R gene expression network associates with human healthy ageing. Immun Ageing 12:21
Pereira DS, Mateo ECC, de Queiroz BZ, Assumpção AM, Miranda AS, Felício DC, Rocha NP, da Cruz dos Anjos DM, Pereira DAG, Teixeira AL, Pereira LSM (2013) TNF-α, IL6, and IL10 polymorphisms and the effect of physical exercise on inflammatory parameters and physical performance in elderly women. Age 35(6):2455–2463
Pes GM, Lio D, Carru C, Deiana L, Baggio G, Franceschi C, Ferrucci L, Oliveri F, Scola L, Crivello A, Candore G, Colonna-Romano G, Caruso C (2004) Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res 16(3):244–248
Pilling LC, Joehanes R, Melzer D, Harries LW, Henley W, Dupuis J, Lin H, Mitchell M, Hernandez D, Ying SX, Lunetta KL, Benjamin EJ, Singleton A, Levy D, Munson P, Murabito JM, Ferrucci L (2015) Gene expression markers of age-related inflammation in two human cohorts. Exp Gerontol 70:37–45
Puzianowska-Kuźnicka M, Owczarz M, Wieczorowska-Tobis K, Nadrowski P, Chudek J, Slusarczyk P, Skalska A, Jonas M, Franek E, Mossakowska M (2016) Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing 13:21. https://doi.org/10.1186/s12979-016-0076-x
Qi H-P, Qu Z-Y, Duan S-R, Wei S-Q, Wen S-R, Bi S (2012) IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer’s disease. PLoS One 7(6):e37858
Rea IM, McNerlan SE, Alexander HD (2000) Serum IL-12 and IL12p40 but not IL-12p70 are increased in the serum of older subjects: relationship to CD3+ and NK subsets. Cytokine 12(2):156–159
Rea IM, Ross OA, Armstrong M, McNerlan S, Alexander DH, Curran MD, Middleton D (2003) Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 124(4):555–561
Rea IM (2017) Towards ageing well: use it or lose it; Exercise, epigenetics and cognition. Biogerontology 18:679–691
Rea IM, Maxwell LD, McNerlan SE, Alexander HD, Curran MD, Middleton D, Ross OA (2013) Killer immunoglobulin-like Receptors (KIR) haplogroups A and B track with natural killer cells and cytokine profile in aged subjects: observations from octo/nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST). Immun Ageing 10(1):35
Rea JNM, Carvalho A, McNerlan SE, Alexander HD, Rea IM (2015) Genes and life-style factors in BELFAST nonagenarians: nature, nurture and narrative. Biogerontology 16(5):587–597
Rea IM, Dellet M, Mills KI, ACUME2 Project (2016) Living long and ageing well: is epigenomics the missing link between nature and nurture. Biogerontology 17(1):33–54
Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101(18):2149–2153
Rink L, Cakman I, Kirchner H (1998) Altered cytokine production in the elderly. Mech Ageing Dev 102:199–209
Rose-John S, Scheller J, Elson G, Jones SA (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80(2):227–236
Ross OA, Curran MD, Meenagh A, Williams F, Barnett YA, Middleton D, Rea IM (2003a) Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 124(2):199–206
Ross OA, Curran MD, Rea IM, Hyland P, Duggan O, Barnett CR, Annett K, Patterson C, Barnett YA, Middleton D (2003b) HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev 124(4):563–567
Rudd AG, Banerjee DK (1989) Interleukin-1 production by human monocytes in ageing and disease. Age Ageing 18(1):43–46
Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C, Passeri M (2008) The immune system in extreme longevity. Exp Gerontol 43(2):61–65
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The Pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Bophys Acta (BBA) Mol Cell Res 1813(5):878–888
Sebastiani P, Solovieff N, Dewan AT, Walsh KM, Puca A, Hartley SW, Melista E, Andersen S, Dworkis DA, Wilk JB, Myers RH, Steinberg MH, Montano M, Baldwin CT, Hoh J, Perls TT (2012) Genetic signatures of exceptional longevity in humans. PLoS One 7(1):e29848
Shaw AC, Goldstein DR, Montgomery RR (2013) Age-dependent dysregulation of innate immunity. Nat Rev Immunol 13(12):875–887
Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10(2):89–102
Skytthe A, Valensin S, Jeune B, Cevenini E, Balard F, Beekman M, Bezrukov V, Blanche H, Bolund L, Broczek K, Carru C, Christensen K, Christiansen L, Collerton JC, Cotichini R, Craen D, AJM, Dato S, Davies K, De Benedictis G, Deiana L, Flachsbart D, Gampe J, Gilbault G, Gonos ES, Haimes E, Hervonen A, Hurme MA, Janiszewska D, Jylhä M, Kirkwood TBL, Kristensen P, Laiho P, Leon A, Marchisio A, Masciulli R, Nebel A, Passarino G, Pelicci G, Peltonen L, Perola M, Poulain M, Rea IM, Remacle J, Robine JM, Schreiber S, Scurti M, Sevini D, Sikora E, Skouteri A, Slagboom PE, Spazzafumo L, Stazi MA, Toccaceli V, Toussaint O, Törnwall O, Vaupel JW, Voutetakis K, Franceschi C (2011) Design, recruitment, logistics, and data management of the GEHA (Genetics of Healthy Ageing) project. Exp Gerontol 46(11):934–945
Smith DE (2011) The biological paths of IL-1 family members IL-18 and IL-33. J Leukoc Biol 89(3):383–392
Soerensen M, Dato S, Tan Q, Thinggaard M, Kleindorp R, Beekman M, Suchiman HE, Jacobsen R, McGue M, Stevnsner T, Bohr VA, de Craen AJ, Westendorp RG, Schreiber S, Slagboom PE, Nebel A, Vaupel JW, Christensen K, Christiansen L (2013) Evidence from case–control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity. Age 35(2):487–500
Spoto B, Mattace-Raso F, Sijbrands E, Leonardis D, Testa A, Pisano A, Pizzini P, Cutrupi S, Parlongo RM, D’Arrigo G, Tripepi G, Mallamaci F, Zoccali C (2014) Association of IL-6 and a functional polymorphism in the IL-6 Gene with cardiovascular events in patients with CKD. Clin J Am Soc Nephrol 10:232–240
Talens RP, Christensen K, Putter H, Willemsen G, Christiansen L, Kremer D, Suchiman HE, Slagboom PE, Boomsma DI, Heijmans BT (2012) Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell 11(4):694–703
Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S (2007) Inflammatory markers and the risk of Alzheimer disease: the Framingham Study Neurology. Neurology 68(22):1902–1908
Tan MS, Yu JT, Jiang T, Zhu XC, Guan HS, Tan L (2014) Il-12/23 p40 inhibition ameliorates alzheimers disease-associated neuropathology and spatial memory in SAMP8 mice. J Alzheimers Dis 38(3):633–646
Thomas K, Radiq S, Frayling T, Ebrahim S, Kumari M, Gallacher J, Ferrucci L, Bandinelli S, Wallace RB, Melzer D, Martin RM, Ben-Shlomo Y (2009) Interleukin-18 polymorphism and physical functioning in older people: a replication study and meta-analysis. J Gerontol A Biol Sci Med Sci 64(11):1177–1182
Tran DQ (2012) TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells. J Mol Cell Biol 4(1):29–37
Trinchieri G (1993) Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 14(7):335–338
Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Jukema JW, Westendorp RG, PROSPER Group (2008) Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain 131(Pt 4):1069–1077
Vieira da Silva Pellegrina D, Severino P, Vieira Barbeiro H, Maziero Andreghetto F, Tadeu Velasco I, Possolo de Souza H et al (2015) Septic shock in advanced age: transcriptome analysis reveals altered molecular signatures in neutrophil granulocytes. PLoS One 10(6):e0128341
Vom Berg J, Prokop S, Miller KR, Obst J, Kälin RE, Lopategui-Cabezas I, Wegner A, Mair F, Schipke CG, Peters O, Winter Y, Becher B, Heppner FL (2012) Inhibition of IL-12/IL-23 signally reduces Alzheimers disease-like pathology and cognitive decline. Nat Med 18(12):1812–1819
Wang XY, Hurme M, Jylha M, Hervonen A (2001) Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev 123:29–38
Wang J, He Y, Yang Y, Song T, Chen N, Zhou Y (2015) Association between the TNF-α G-308A polymorphism and risk of ischemic heart disease: a meta-analysis. Int J Clin Exp Med 8(6):8880–8892
Weiss TW, Arnesen H, Seljieflot I (2013) Components of the Interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Metabolism 62(7):1008–1013
Welsh P, Murray HM, Ford I, Trompet S, de Craen AJ, Jukema JW, Stott DJ, McInnes IB, Packard CJ, Westendorp RG, Sattar N, PROSPER Study Group (2011) Circulating Interleukin-10 and risk of cardiovascular events a prospective study in the elderly at risk. Arterioscler Thromb Vasc Biol 31(10):2338–2344
Westendorp RG, Langermans JAM, Huizinga TWJ, Elouali AH, Verweij CL, Boomsma DI, Vandenbrouke JP (1997) Genetic influence on cytokine production in meningococcal disease. Lancet 349:170–173
Wieczorowska-Tobis K, Niemir ZI, Podkówka R, Korybalska K, Mossakowska M, Bręborowicz A (2006) Can an increased level of circulating IL-8 be a predictor of human longevity? Med Sci Monit 12(3):CR118–CR121
Willcox BJ, Willcox DC, He Q, Curb JD, Suzuki M (2006) Siblings of Okinawan centenarians share lifelong mortality advantages. J Gerontol A Biol Sci Med Sci 61(4):345–354
Williams L, Laura Bradley L, Smith A, Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172(1):567–576
Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP (2011) Human tumour immune evasion via TGF-β blocks NK cell activation but not survival aloowing therapeutic resporation of anti-tumour activity. PLoS One 6(9):e22842
Yan J, Zhang H, Yin Y, Li J, Tang Y, Purkayastha S, Li L, Cai D (2014) Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response. Nat Med 20:1001–1008
Yoshimura A, Wakabayashi Y, Mori T (2010) Cellular and molecular basis for the regulation of inflammation by TGF-β. J Biochem 147(6):781–792
Zhou L, Cai J, Liu G, Wei Y, Tang H (2012) Associations between Interleukin-1 gene polymorphisms and coronary heart disease risk: a meta-analysis. PLoS One 7(9):e45641
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
McNerlan, S.E., Ross, O.A., Maeve Rea, I. (2018). Cytokine Expression and Production Changes in Very Old Age. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook of Immunosenescence. Springer, Cham. https://doi.org/10.1007/978-3-319-64597-1_40-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-64597-1_40-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64597-1
Online ISBN: 978-3-319-64597-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences